Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Trading 9.3% Higher – Here’s Why

Shares of Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) were up 9.3% during trading on Monday . The company traded as high as $17.29 and last traded at $17.29. Approximately 666 shares were traded during mid-day trading, a decline of 96% from the average daily volume of 17,672 shares. The stock had previously closed at $15.82.

Analyst Ratings Changes

A number of analysts have recently weighed in on TLX shares. UBS Group initiated coverage on Telix Pharmaceuticals Limited American Depositary Shares in a research report on Friday, November 15th. They set a “buy” rating and a $21.00 price target on the stock. William Blair raised Telix Pharmaceuticals Limited American Depositary Shares to a “strong-buy” rating in a research report on Tuesday, November 19th.

Telix Pharmaceuticals Limited American Depositary Shares Stock Up 3.1 %

Telix Pharmaceuticals Limited American Depositary Shares Company Profile

Telix Pharmaceuticals Limited is a biopharmaceutical company which focused on the development and commercialisation of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It involved in developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases.